ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

October 28, 2005

In Brief: Hospices Urges To Develop Program For AIDs Victims; Companies Give $25,5000 To NCI Fund

October 25, 1985

ONS Votes to Push Congress on DRGs

June 1, 1984

FDA Grants Priority Review To Two Drugs in NSCLC

February 22, 2013

On Capitol Hill: Funding Outlook Brighter For NIH and NCI as appropriators Provide Increases

October 1, 1999